167 related articles for article (PubMed ID: 10871412)
1. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.
Li QX; Robbins JM; Welch PJ; Wong-Staal F; Barber JR
Nucleic Acids Res; 2000 Jul; 28(13):2605-12. PubMed ID: 10871412
[TBL] [Abstract][Full Text] [Related]
2. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.
Beger C; Pierce LN; Kruger M; Marcusson EG; Robbins JM; Welcsh P; Welch PJ; Welte K; King MC; Barber JR; Wong-Staal F
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):130-5. PubMed ID: 11136250
[TBL] [Abstract][Full Text] [Related]
3. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
6. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.
Amarzguioui M; Brede G; Babaie E; Grotli M; Sproat B; Prydz H
Nucleic Acids Res; 2000 Nov; 28(21):4113-24. PubMed ID: 11058107
[TBL] [Abstract][Full Text] [Related]
7. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.
Greenberg RA; Allsopp RC; Chin L; Morin GB; DePinho RA
Oncogene; 1998 Apr; 16(13):1723-30. PubMed ID: 9582020
[TBL] [Abstract][Full Text] [Related]
8. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
Bramlage B; Luzi E; Eckstein F
Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
[TBL] [Abstract][Full Text] [Related]
10. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
11. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
12. Hairpin ribozyme specificity in vivo: a case of promiscuous cleavage.
Denman RB
Biochem Biophys Res Commun; 1999 Apr; 257(2):356-60. PubMed ID: 10198217
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
14. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme.
Song MS; Jeong JS; Cho KS; Lee SW
Exp Mol Med; 2007 Dec; 39(6):722-32. PubMed ID: 18160843
[TBL] [Abstract][Full Text] [Related]
15. In vitro cleavage of an N-ras messenger-like RNA by a ribozyme.
Stephenson P; Gibson I
Antisense Res Dev; 1991; 1(3):261-8. PubMed ID: 1668256
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
Xing Z; Mahadeviah S; Whitton JL
Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
[TBL] [Abstract][Full Text] [Related]
17. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.
Dawson PA; Marini JC
Nucleic Acids Res; 2000 Oct; 28(20):4013-20. PubMed ID: 11024182
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
[TBL] [Abstract][Full Text] [Related]
19. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
Li YL; Torchet C; Vergne J; Maurel MC
Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
[TBL] [Abstract][Full Text] [Related]
20. Triple ribozyme-mediated down-regulation of the retinoblastoma gene.
Benedict CM; Pan W; Loy SE; Clawson GA
Carcinogenesis; 1998 Jul; 19(7):1223-30. PubMed ID: 9683181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
